Benign clinical course in homozygous sickle cell disease: A search for predictors

Journal of Clinical Epidemiology

Volumn 50, Issue 2, 1997, Pages 121-126

  Thomas, P W ^a   Higgs, D R ^b   Serjeant, G R ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Alpha thalassemia; Benign clinical course; Fetal hemoglobin (HbF); Homozygous sickle cell disease (SS)

Indexed keywords

ALPHA GLOBIN; HEMOGLOBIN F;

ARTICLE; COHORT ANALYSIS; DISEASE COURSE; GENE DELETION; HUMAN; JAMAICA; PRIORITY JOURNAL; SICKLE CELL; SICKLE CELL ANEMIA; SOCIAL STATUS; STEADY STATE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FETAL HEMOGLOBIN; GENE DELETION; GLOBINS; HOMOZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; JAMAICA; PROGNOSIS; SICKLE CELL TRAIT; SOCIAL CLASS;

EID: 0030890407     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00320-4     Document Type: Article

References (32)

1. Serjeant GR, Richards R, Barbor PRH, Milner PF. Relatively benign sickle-cell anaemia in 60 patients aged over 30 in the West Indies. Br Med J 1968; 3: 86-91.
2. Serjeant GR. Sickle Cell Disease. 2nd Ed. Oxford: Oxford University Press; 1992.
3. Steinberg MH, Dreiling BJ, Morrison FS, Necheles TF. Mild sickle cell disease. Clinical and laboratory studies. JAMA 1973; 224: 317-321.
4. Jackson JF, Odom JL, Bell WN. Amelioration of sickle cell disease by persistent fetal hemoglobin. JAMA 1961; 177: 125-127.
5. Powars DR, Schroeder WA. Progress in the natural history studies of the clinical severity of sickle cell disease: Epidemiologic aspects. In: Biochemical and Clinical Aspects of Hemoglobin Abnormalities. (Caughey WS, Ed.) New York: Academic Press; 1978, 151-164.
6. Cameron BF, Christian E, Lobel JS, Gaston MH. Evaluation of clinical severity in sickle cell disease. J Natl Med Assn 1985; 75: 483-487.
7. Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, Grandison Y, Lowrie Y, Mason KP, Serjeant BE, Serjeant GR. The interaction of alpha thalassemia and homozygous sickle-cell disease. N Engl J Med 1982; 306: 1441-1446.
8. Bailey K, Morris JS, Thomas P, Serjeant GR. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 1992; 67: 517-520.
9. Serjeant BE, Forbes M, Williams LL, Serjeant GR. Screening cord bloods for detection of sickle cell disease in Jamaica. Clin Chem 1974; 20: 666-669.
10. Serjeant BE, Clarke JM, Desai P, Serjeant GR. A simple micromethod for the measurement of fetal haemoglobin. J Clin Pathol 1975; 28: 761-764.
11. Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature 1959; 184: 1877-1878.
12. + thalassaemia traits in Jamaican negroes. Br J Haematol 1977; 36: 161-170.
13. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989; 84: 500-508.
14. Baum KF, Dunn DT, Maude GH, Serjeant GR. The painful crisis of homozygous sickle cell disease: A study of risk factors. Arch Intern Med 1987; 147: 1231-1234.
15. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease: Rates and risk factors. N Engl J Med 1991; 325: 11-15.
16. Hawker H, Neilson H, Hayes RJ, Serjeant GR. Haematologic factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease. Br J Haematol 1982; 50: 29-34.
17. Hayes RJ, Condon PI, Serjeant GR. Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease. Br J Ophthalmol 1981; 65: 29-35.
18. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS. The acute chest syndrome in sickle cell disease: Incidence and risk factors. Blood 1994; 84: 643-649.
19. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360-366.
20. Platt OS, Bramhilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
21. Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Luhin BH, Kan YW, Mentzer WC. Concurrent sickle-cell anemia and alpha thalassemia: Effect on severity of anemia. N Engl J Med 1982; 396: 270-274.
22. Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, Cedeno M, Rieder RF, Wilson JT, Milner P, West S. Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood 1984; 63: 1355-1360.
23. Embury SH, Clark MR, Monroy G, Mohandas N. Concurrent sickle cell anemia and alpha thalassemia: Effect on pathological properties of sickle erythrocytes. J Clin Invest 1984; 73: 116-123.
24. Fahry ME, Mears JG, Patel P, Schaefer-Rego K, Carmichael LD, Martinez G, Nagel RL. Dense cells in sickle cell anemia: The effects of gene interaction. Blood 1984; 64: 1042-1046.
25. Serjeant BE, Mason KP, Kenny MW, Stuart J, Higgs DR, Weatherall DJ, Hayes RJ, Serjeant GR. Effects of alpha thalassaemia on the theology of homozygous sickle cell disease. Br J Haematol 1983; 55: 479-486.
26. DeCeulaer K, Higgs DR, Weatherall DJ, Hayes RJ, Serjeant BE, Serjeant GR. Alpha thalassemia reduces the hemolytic rate in homozygous sickle cell disease. N Engl J Med 1983; 309: 189-190.
27. Mears JG, Lachman HM, Labie D, Nagel RL. Alpha thalassemia is related to prolonged survival in sickle cell anemia. Blood 1983; 62: 286-290.
28. Padmos MA, Roberts GT, Sackey K, Kulozik A, Bail S, Morris JS, Serjeant BE, Serjeant GR. Two different forms of homozygous sickle cell disease occur in Saudi Arabia. Br J Haematol 1991; 79: 93-98.
29. Gelpi AP. Benign sickle cell disease in Saudi Arabia: Survival estimate and population dynamics. Clin Genet 1979; 15: 307-310.
30. Powars DR, Schroeder WA, Weiss JN, Chan LS, Azen AP. Lack of influence of fetal hemoglohin levels or erythrocyte indices on the severity of sickle cell anemia. J Clin Invest 1980; 65: 732-740.
31. Powars DR, Weiss JN, Chan LS, Schroeder WA. Is there a threshold level of fetal hemoglohin that ameliorates morbidity in sickle cell anemia. Blood 1984; 63: 921-926.
32. Stevens MCG, Hayes RJ, Vaidya S, Serjeant GR. Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood. J Pediatr 1981; 98: 37-41.